Differentiation-dependent regulation of the cyclooxygenase cascade during adipogenesis suggests a complex role for prostaglandins

Diabetes, Obesity and Metabolism

Volumn 8, Issue 1, 2006, Pages 83-93

  Xie, Y ^a   Kang, X ^a   Ackerman IV, W E ^a   Belury, M A ^a   Koster, C ^a   Rovin, B H ^b   Landon, M B ^a   Kniss, D A ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

3T3 L1 cell; Adipogenesis; Cyclooxygenase; Obesity; PPAR ; Prostaglandin D synthase; Prostaglandin E synthase; Prostaglandins; Type 2 diabetes

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; 6 OXOPROSTAGLANDIN F1 ALPHA; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; LIPOCALIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTAGLANDIN; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE;

ADIPOCYTE; ADIPOGENESIS; ANALYSIS OF VARIANCE; ANIMAL CELL; ARACHIDONIC ACID METABOLISM; ARTICLE; CELL DIFFERENTIATION; CELL NUCLEUS; CELL STRAIN 3T3; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME IMMUNOASSAY; ENZYME LOCALIZATION; GENE EXPRESSION; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; MICROSOME; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PROADIPOCYTE; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

EID: 33646008282     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2005.00472.x     Document Type: Article

References (47)

1. Lewis GF, Carpentier A, Adeli K, Giacca A. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 2002; 23: 201-229.
2. Spiegelman BM, Flier JS. Obesity and the regulation of energy balance. Cell 2001; 104: 531-535.
3. Gregoire FM, Smas CM, Sul HS. Understanding adipocyte differentiation. Physiol Rev 1998; 78: 783-809.
4. Rangwala SM, Lazar MA. Transcriptional control of adipogenesis. Annu Rev Nutr 2000; 20: 535-559.
5. Willson TM, Lambert MH, Kliewer SA. Peroxisome proliferator-activated receptor-γ and metabolic disease. Annu Rev Biochem 2001; 70: 341-367.
6. Walczak R, Tontonoz P. PPARadigms and PPARdoxes: Expanding roles for PPAR-γ in the control of lipid metabolism. J Lipid Res 2002; 43: 177-186.
7. Murphy GJ, Holder JC. PPAR-γ agonists: Therapeutic role in diabetes, inflammation and cancer. Trends Pharmacol Sci 2000; 21: 469-474.
8. Hertzel AV, Bernlohr DA. Regulation of adipocyte gene expression by polyunsaturated fatty acids. Mol Cell Biochem 1998; 188: 33-39.
9. 2 is a ligand for the adipocyte determination factor PPAR-γ. Cell 1995; 83: 803-812.
10. 2 metabolite binds peroxisome proliferator-activated receptor-γ and promotes adipocyte differentiation. Cell 1995; 83: 813-819.
11. Smith WL, Garavito RM, DeWitt DL. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 1996; 271: 33157-33160.
12. DeWitt DL. Prostaglandin endoperoxide synthase: Regulation of enzyme expression. Biochim Biophys Acta 1991; 1083: 121-134.
13. Reddy ST, Herschman HR. Ligand-induced prostaglandin synthesis requires expression of the TIS10/PGS-2 prostaglandin synthase gene in murine fibroblasts and macrophages. J Biol Chem 1994; 269: 15473-15480.
14. Dubois RN, Abramson SB, Crofford L et al. Cyclooxygenase in biology and disease. FASEB J 1998; 12: 1063-1073.
15. Kozak KR, Crews BC, Morrow JD et al. Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides. J Biol Chem 2002; 277: 44877-44885.
16. Suzuki T, Watanabe K, Kanaoka Y, Sato T, Hayaishi O. Induction of hematopoietic prostaglandin D synthase in human megakaryocytic cells by phorbol ester. Biochem Biophys Res Commun 1997; 241: 288-293.
17. Lazarus M, Kubata BK, Eguchi N, Fujitani Y, Urade Y, Hayashi O. Biochemical characterization of mouse microsomal prostaglandin E synthase-1 and its colocalization with cyclooxygenase-2 in peritoneal macrophages. Arch Biochem Biophys 2002; 397: 336-341.
18. 2 synthesis. J Biol Chem 2000; 275: 32775-32782.
19. Student AK, Hsu RY, Lane MD. Induction of fatty acid synthetase synthesis in differentiating 3T3-L1 preadipocytes. J Biol Chem 1980; 255: 4745-4750.
20. 27 trophoblast-like cells. Placenta 2001; 22: 80-89.
21. Green H, Kehinde O. Sublines of mouse 3T3 cells that accumulate lipid. Cell 1974; 1: 113-118.
22. Hyman BT, Stoll LL, Spector AA. Prostaglandin production by 3T3-L1 cells in culture. Biochim Biophys Acta 1982; 713: 375-385.
23. Inoue H, Yokoyama C, Hara S, Tone Y, Tanabe T. Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells: Involvement of both nuclear factor for interleukin-6 expression site and cAMP response element. J Biol Chem 1995; 270: 24965-24971.
24. Kujubu DA, Fletcher BS, Varnum BC, Lim RW, Herschman HR. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 1991; 266: 12866-12872.
25. Yan H, Kermouni A, Abdel-Hafez M, Lau DCW. Role of cyclooxygenases COX-1 and COX-2 in modulating adipogenesis in 3T3-L1 cells. J Lipid Res 2003; 44: 424-429.
26. 2 synthase enzymes and PPAR-γ are co-expressed in mouse 3T3-L1 adipocytes and human tissues. Prostaglandins Other Lipid Mediat 2003; 70: 267-284.
27. 2 synthase that acts in concert with cyclooxygenase-2. J Biol Chem 2000; 275: 32783-32792.
28. Petersen RK, Jorgensen C, Rustan AC et al. Arachidonic acid-dependent inhibition of adipocyte differentiation requires PKA activity and is associated with sustained expression of cyclooxygenases. J Lipid Res 2003; 44: 2320-2330.
29. Needleman P, Turk J, Jakschik BA, Morrison AR, Lefkowith JB. Arachidonic acid metabolism. Annu Rev Biochem 1986; 55: 69-102.
30. 2α inhibits the differentiation of adipocyte precursors in primary culture. Biochem Biophys Res Commun 1992; 183: 438-442.
31. Massiera F, Saint-Marc P, Seydoux J et al. Arachidonic acid and prostacyclin signaling promote adipose tissue development: A human health concern? J Lipid Res 2003; 44: 271-279.
32. Chawla A, Repa JJ, Evans RM, Mangelsdorf DJ. Nuclear receptors and lipid physiology: Opening the X-files. Science 2001; 294: 1866-1870.
33. Kim JB, Wright HM, Spiegelman BM. ADD1/SREBP1 activates PPAR-γ through the production of endogenous ligand. Proc Natl Acad Sci USA 1998; 95: 4333-4337.
34. Lazar MA. Becoming fat. Genes Dev 2002; 16: 1-5.
35. Dussault I, Forman BM. Prostaglandins and fatty acids regulate transcriptional signaling via the peroxisome proliferator activated receptor nuclear receptors. Prostaglandins Other Lipid Mediat 2000; 62: 1-13.
36. Jones AB. Peroxisome proliferator-activated receptor (PPAR) modulators: Diabetes and beyond. Med Res Rev 2001; 21: 540-552.
37. 2 and the ligation of PPAR-γ. J Clin Invest 2003; 112: 945-955.
38. 2: Endogenous PPAR-γ ligand or minor eicosanoid degradation product? J Clin Invest 2003; 112: 828-830.
39. Tamori Y, Masugi J, Nishino N, Kasuga M. Role of peroxisome proliferator-activated receptor-α in maintenance of the characteristics of mature 3T3-L1 adipocytes. Diabetes 2002; 51: 2045-2055.
40. Imai T, Takakuwa R, Marchand S et al. Peroxisome proliferator-activated receptor-γ is required in mature white and brown adipocytes for their survival in the mouse. Proc Natl Acad Sci USA 2004; 101: 4543-4547.
41. 2α. Biochim Biophys Acta 1991; 1091: 364-369.
42. Casimir DA, Miller CW, Ntambi JM. Preadipocyte differentiation blocked by prostaglandin stimulation of prostanoid FP receptor in murine 3T3-L1 cells. Differentiation 1996; 60: 203-210.
43. Hu E, Kim JB, Sarraf P, Spiegelman BM. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPAR-γ. Science 1996; 274: 2100-2103.
44. Willoughby D, Lawrence T, Colville-Nash P. Cyclooxygenase-2 in experimental models of inflammation. In: Vane JR, Botting RM eds. Therapeutic roles of selective COX-2 inhibitors. Cambridge: William Harvey Press, 2001; 95-127.
45. Mancini JA, Blood K, Guay J et al. Cloning, expression, and upregulation of inducible rat prostaglandin E synthase during lipopolysaccharide-induced pyresis and adjuvant-induced arthritis. J Biol Chem 2001; 276: 4469-4475.
46. Ferry G, Bruneau V, Beauverger P et al. Binding of prostaglandins to human PPAR-γ: Tool assessment and new natural ligands. Eur J Pharmacol 2001; 417: 77-89.
47. 2 receptors. Proc Natl Acad Sci USA 1998; 95: 15792-15797.